quinaprilat has been researched along with rosiglitazone in 3 studies
Studies (quinaprilat) | Trials (quinaprilat) | Recent Studies (post-2010) (quinaprilat) | Studies (rosiglitazone) | Trials (rosiglitazone) | Recent Studies (post-2010) (rosiglitazone) |
---|---|---|---|---|---|
92 | 23 | 4 | 4,749 | 556 | 1,818 |
Protein | Taxonomy | quinaprilat (IC50) | rosiglitazone (IC50) |
---|---|---|---|
CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1.1 | |
Bile salt export pump | Homo sapiens (human) | 4.5853 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 4.069 | |
Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 0.08 | |
Thromboxane-A synthase | Homo sapiens (human) | 3.56 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.832 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.2481 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.038 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.048 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.048 | |
Sodium/bile acid cotransporter | Homo sapiens (human) | 5.1 | |
CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 2.29 | |
CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 0.731 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
3 other study(ies) available for quinaprilat and rosiglitazone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |